Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to -$324.0 million.

  • Bristol Myers Squibb's Change in Taxes fell 36776.86% to -$324.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.0 million, marking a year-over-year increase of 9968.25%. This contributed to the annual value of -$4.0 million for FY2025, which is 9968.25% up from last year.
  • Bristol Myers Squibb's Change in Taxes amounted to -$324.0 million in Q4 2025, which was down 36776.86% from $887.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Change in Taxes registered a high of $1.0 billion during Q4 2023, and its lowest value of -$2.1 billion during Q2 2023.
  • Over the past 5 years, Bristol Myers Squibb's median Change in Taxes value was -$134.0 million (recorded in 2021), while the average stood at -$217.6 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Change in Taxes tumbled by 222272.73% in 2021, and later surged by 35488.51% in 2025.
  • Bristol Myers Squibb's Change in Taxes (Quarter) stood at -$222.0 million in 2021, then tumbled by 401.35% to -$1.1 billion in 2022, then surged by 193.8% to $1.0 billion in 2023, then plummeted by 88.41% to $121.0 million in 2024, then plummeted by 367.77% to -$324.0 million in 2025.
  • Its last three reported values are -$324.0 million in Q4 2025, $887.0 million for Q3 2025, and -$621.0 million during Q2 2025.